209 related articles for article (PubMed ID: 22747704)
1. Case report of atopic dermatitis with refractory pruritus markedly improved with the novel use of clonidine and trimeprazine.
Genois A; Haig M; Des Roches A; Sirard A; Le May S; McCuaig CC
Pediatr Dermatol; 2014; 31(1):76-9. PubMed ID: 22747704
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
[TBL] [Abstract][Full Text] [Related]
3. Relieving the pruritus of atopic dermatitis: a meta-analysis.
Sher LG; Chang J; Patel IB; Balkrishnan R; Fleischer AB
Acta Derm Venereol; 2012 Sep; 92(5):455-61. PubMed ID: 22773026
[TBL] [Abstract][Full Text] [Related]
4. Antipruritic hydrogel for the treatment of atopic dermatitis: an open-label pilot study.
Draelos ZD
Cutis; 2012 Aug; 90(2):97-102. PubMed ID: 22988654
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model.
Yamamoto Y; Otsuka A; Nakashima C; Ishida Y; Honda T; Egawa G; Amano W; Usui K; Hamada Y; Wada M; Tanimoto A; Konishi N; Hayashi M; Matsushita M; Kabashima K
J Dermatol Sci; 2020 Feb; 97(2):161-164. PubMed ID: 31924380
[No Abstract] [Full Text] [Related]
6. Antihistamines for atopic dermatitis.
Phillips RL; Koenig CJ
J Fam Pract; 2000 Mar; 49(3):267. PubMed ID: 10735488
[No Abstract] [Full Text] [Related]
7. New therapies for controlling atopic itch.
Furue M; Kadono T
J Dermatol; 2015 Sep; 42(9):847-50. PubMed ID: 26332459
[TBL] [Abstract][Full Text] [Related]
8. Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis.
Takeuchi S; Oba J; Esaki H; Furue M
J Dermatol; 2018 Feb; 45(2):158-164. PubMed ID: 29168215
[TBL] [Abstract][Full Text] [Related]
9. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
10. Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases.
Lim KM; Park YH
Arch Pharm Res; 2012 Mar; 35(3):393-6. PubMed ID: 22477184
[TBL] [Abstract][Full Text] [Related]
11. Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 Inhibitor.
Yosipovitch G; Gold LF; Lebwohl MG; Silverberg JI; Tallman AM; Zane LT
Acta Derm Venereol; 2018 Apr; 98(5):484-489. PubMed ID: 29363715
[TBL] [Abstract][Full Text] [Related]
12. Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis.
Lönndahl L; Holst M; Bradley M; Killasli H; Heilborn J; Hall MA; Theodorsson E; Holmberg J; Nordlind K
Acta Derm Venereol; 2018 Mar; 98(3):324-328. PubMed ID: 29182791
[TBL] [Abstract][Full Text] [Related]
13. Improvement in pruritus in children with atopic dermatitis using pimecrolimus cream 1%.
Fowler J; Johnson A; Chen M; Abrams K
Cutis; 2007 Jan; 79(1):65-72. PubMed ID: 17330625
[TBL] [Abstract][Full Text] [Related]
14. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
Abramovits W; Oquendo M
Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
[TBL] [Abstract][Full Text] [Related]
15. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
16. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component.
Munday J; Bloomfield R; Goldman M; Robey H; Kitowska GJ; Gwiezdziski Z; Wankiewicz A; Marks R; Protas-Drozd F; Mikaszewska M
Dermatology; 2002; 205(1):40-5. PubMed ID: 12145433
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of adenosylcobalamin in relieving xerotic pruritus symptoms of atopic dermatitis.
Kim HK; Kim BJ; Suk JM; Park JO; Jung SW; Sun SO; Koo J; Lee SI
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):254-5. PubMed ID: 23506619
[No Abstract] [Full Text] [Related]
18. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
Kagawa Y; Izawa K; Yano H; Kamei C
Pharmacology; 2010; 85(5):286-94. PubMed ID: 20453552
[TBL] [Abstract][Full Text] [Related]
19. [Clinical effects of olopatadine hydrochloride on pruritus in skin diseases].
Niide M; Okubo Y; Irisawa R; Tsuboi R
Arerugi; 2006 Oct; 55(10):1327-36. PubMed ID: 17072113
[TBL] [Abstract][Full Text] [Related]
20. Pruritus and nocturnal wakenings.
Savin JA; Adam K; Oswald I; Paterson WD
J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):767-8. PubMed ID: 2278591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
